The number of long noncoding RNA (lncRNA) genes almost equals to the number of protein coding genes. However, the functions of most of lncRNA genes are unknown. Differential expression of lncRNA genes in different hematopoietic lineages implies that lncRNA genes are important regulators for hematopoiesis. One subgroup of lncRNA genes consists of antisense RNA genes that are transcribed in the opposite direction of their sense counterparts. Many genes important for hematopoiesis such as RBM15, PU.1, WT1, p53 and RUNX1 have antisense counterparts. In this proposed study, we plan to investigate the molecular details on how an antisense RNA (AS-RBM15) of RBM15 gene regulates hematopoiesis. We reported that AS-RBM15 promotes RBM15 protein translation via interaction with the 5'UTR of RBM15 mRNA. Furthermore, AS-RBM15 may promote megakaryocyte differentiation via RBM15-dependent and RBM15-independent pathways. We plan to address the hypothesis that AS-RBM15 regulates hematopoiesis via enhancing protein translation. 1) Determine how the cytoplasmic AS-RBM15 regulates RBM15 protein translation in hematopoietic cells. In this specific aim, we plan to understand how the RNA-RNA interaction involving AS-RBM15 and uORF in 5'UTR of RBM15 mRNA regulates RBM15 protein translation, and what kind of hematopoietic signals regulate AS-RBM15-mediated protein translation. 2) Determine the in vivo biological functions of mouse AS-Rbm15 in hematopoiesis. Although the primary RNA sequences between humans and mice are very different, the biological functions of AS-RBM15 genes may still be conserved. We plan to use mouse leukemia cell lines to investigate AS-Rbm15's molecular functions and to use bone marrow transplantation assays to investigate hematopoiesis in vivo. Accomplishing this proposal will provide us with new paradigms on RNA-mediated regulation, establish methods to study other antisense RNA genes and open up new avenues to understand the roles of long noncoding RNA in normal hematopoiesis.

Public Health Relevance

This project is aligned with mission of NIDDK as it focuses on the function of a long antisense noncoding RNA (AS-RBM15) in hematopoiesis via promoting RBM15 protein translation. In addition, establishing new antisense mouse models will offer new avenues to study normal hematopoiesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK110574-02
Application #
9542789
Study Section
Molecular and Cellular Hematology Study Section (MCH)
Program Officer
Bishop, Terry Rogers
Project Start
2017-08-15
Project End
2020-07-31
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Biochemistry
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Su, Hairui; Sun, Chiao-Wang; Liu, Szu-Mam et al. (2018) Defining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1. Blood Adv 2:2829-2836